Cytiva Localizes Production of Automated Industrial Chromatography Columns in China
Cytiva, a Danaher operating company, has announced the local production of its automated industrial chromatography column, a flagship downstream purification platform for biopharmaceutical manufacturing. Produced through Cytiva’s expanding manufacturing network in China, the launch marks another milestone in the company’s localization strategy to support the country’s growing biopharmaceutical industry.
Built to global quality standards and featuring adaptive column-packing technology, the system is designed to improve process consistency and manufacturing efficiency. Together with Cytiva’s production sites in Beijing, Tonglu, and Zhuhai, the initiative strengthens local supply chain resilience and enables faster, more flexible delivery of critical bioprocessing technologies to the Chinese market.
YHLO Biotech Hosts Vietnamese Laboratory Experts to Advance International Diagnostics Collaboration
YHLO Biotech welcomed a delegation of 15 leading laboratory specialists from Vietnam’s top hospitals for a technical exchange in Beijing, including visits to Peking Union Medical College Hospital and QianMai Medical Laboratory. The program showcased AI-assisted autoimmune diagnostics and high-throughput laboratory automation, highlighting advances in standardized and intelligent clinical testing.
The exchange reflects YHLO’s broader efforts to strengthen international collaboration in laboratory medicine and support the adoption of advanced diagnostic technologies across Southeast Asia through knowledge sharing and clinical partnerships.
Maccura and Zhifang Technology Partner to Advance Smart Laboratory Solutions
Maccura has signed a strategic partnership with Zhifang Technology to accelerate the development of integrated smart laboratories by combining IVD automation with laboratory informatics. The collaboration will embed Zhifang’s software capabilities into Maccura’s intelligent laboratory platform, connecting instruments, workflows, quality control, data, and operations within a unified ecosystem.
The partnership reflects the industry's shift from standalone laboratory automation toward AI-enabled, fully connected laboratory environments that improve operational efficiency, streamline workflows, and support more intelligent clinical decision-making.
DIRUI Medical and Aimagine Care Technology Join Forces to Expand Smart Hematology Solutions Globally
DIRUI Medical and Aimagine Care Technology have signed a strategic agreement to jointly expand overseas markets, combining DIRUI's hematology analyzers with Aimagine Care 's AI-powered automated blood smear preparation, staining, and morphology analysis system. The integrated solution delivers a complete smart hematology workflow—from routine blood cell counting to AI-assisted morphological review—helping laboratories improve automation, standardization, and diagnostic efficiency. Leveraging DIRUI's global distribution network and Aimagine Care 's AI expertise, the partnership aims to accelerate the international adoption of intelligent hematology laboratory solutions and strengthen the global presence of Chinese IVD innovation.
Shanghai BioScience Co., Ltd. and Geneus Technologies Partner to Expand Single-Molecule Sequencing
BioScience and Geneus Technologies have launched a strategic partnership to accelerate the commercialization of single-molecule sequencing. The collaboration spans product deployment, technical services, market expansion, and talent development, combining BioScience’s nationwide laboratory network with Geneus’s G-seq sequencing platform.
As part of the agreement, BioScience has completed a multi-million-yuan procurement of G-seq500 sequencers, which will be deployed across 10 laboratories in China. The partnership aims to expand access to high-performance sequencing services while strengthening the domestic single-molecule sequencing ecosystem through joint technology and service capabilities.
